New England Capital Financial Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5K | Hold |
1,153
| – | – | ﹤0.01% | 248 |
|
|
2025
Q1 | $9.17K | Hold |
1,153
| – | – | ﹤0.01% | 242 |
|
|
2024
Q4 | $6.26K | Buy |
1,153
+260
| +29% | +$1.41K | ﹤0.01% | 259 |
|
|
2024
Q3 | $6.45K | Buy |
893
+243
| +37% | +$1.76K | ﹤0.01% | 255 |
|
|
2024
Q2 | $7.06K | Buy |
650
+516
| +385% | +$5.6K | ﹤0.01% | 243 |
|
|
2024
Q1 | $2.51K | Hold |
134
| – | – | ﹤0.01% | 302 |
|
|
2023
Q4 | $2.9K | Hold |
134
| – | – | ﹤0.01% | 307 |
|
|
2023
Q3 | $2.76K | Hold |
134
| – | – | ﹤0.01% | 300 |
|
|
2023
Q2 | $6.3K | Hold |
134
| – | – | ﹤0.01% | 250 |
|
|
2023
Q1 | $5.62K | Hold |
134
| – | – | ﹤0.01% | 285 |
|
|
2022
Q4 | $5.7K | Buy |
+134
| New | +$5.7K | ﹤0.01% | 287 |
|